GL1X · GenesisL1 explorer

Research workbench

Structure of a highly potent short-chain galactosyl ceramide agonist bound to CD1D

Analyse Structure of a highly potent short-chain galactosyl ceramide agonist bound to… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
1Z5L
Type
protein
Length
727 residues
Chains
4
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
T-cell surface glycoprotein CD1D antigen; Beta-2-microglobulin
Ligands
PBS, R16, NAG
Pockets
9 · best druggability 0.86

Structure

x-ray diffraction · 3 distinct chains · 22% helix, 44% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AT-cell surface glycoprotein CD1D antigenprotein26526% helix, 42% strand—
B, DBeta-2-microglobulinprotein980% helix, 52% strand—
CT-cell surface glycoprotein CD1D antigenprotein26626% helix, 43% strand—

Ligands and binding sites

  • PBS · (2S,3S,4R)-N-octanoyl-1-[(alpha-D-galactopyranosyl) oxy]-2-amino-octadecane-3,4-diol · ligand · 2 copies · chains A, C
  • R16 · Hexadecane · ligand · 2 copies · chains A, C
  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 7 copies · chains A, C

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

9 pockets found on a 1 Å grid, 4 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15970.860.9057PBS, R16
25800.850.8956PBS, R16
39090.740.7896empty
44240.650.7846empty
51410.440.7622empty

Interfaces

4 interfaces between chains.

  • A–B · 1299 Ų buried · 12 hydrogen bonds · protein-protein
  • C–D · 1233 Ų buried · 13 hydrogen bonds · protein-protein
  • A–C · 297 Ų buried · 2 hydrogen bonds · protein-protein
  • B–C · 72 Ų buried · 0 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 6 disulfide, 5 glycan (disulfide, N-glycosylation).

Compared structures

  • 1Z5L · Structure of a highly potent short-chain galactosyl ceramide agonist bound to CD1D · the same entry in another collection · chain C against C, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.